Cargando…

Fertility-Sparing Treatment and Assisted Reproductive Technology in Patients with Endometrial Carcinoma and Endometrial Hyperplasia: Pregnancy Outcomes after Embryo Transfer

SIMPLE SUMMARY: Given that younger women with endometrial carcinoma (EMCA)/endometrial hyperplasia (EH) tend to have better prognoses than older women and fertility-sparing treatment continues to be recognized as acceptable management, the importance of understanding pregnancy outcomes in this cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedlander, Hilary, Blakemore, Jennifer K., McCulloh, David H., Fino, M. Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093683/ https://www.ncbi.nlm.nih.gov/pubmed/37046784 http://dx.doi.org/10.3390/cancers15072123

Ejemplares similares

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
por: Contreras, Nayanar-Adela, et al.
Publicado: (2022)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes
por: Mutlu, Levent, et al.
Publicado: (2022)

Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in New York City
por: Voigt, Paxton E., et al.
Publicado: (2020)

Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience
por: Shikeli, Sumaya, et al.
Publicado: (2020)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
por: Murakami, Isao, et al.
Publicado: (2023)

Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
por: Yang, Bingyi, et al.
Publicado: (2018)

Fertility-sparing treatment in women with endometrial cancer
por: Won, Seyeon, et al.
Publicado: (2020)

Fertility-sparing treatment for patients with endometrial carcinoma
por: Ind, T
Publicado: (2023)

Fertility-sparing treatment for endometrial cancer and atypical endometrial hyperplasia in patients with Lynch Syndrome: Molecular diagnosis after immunohistochemistry of MMR proteins
por: Catena, Ursula, et al.
Publicado: (2022)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Effects of Weight Status and Related Metabolic Disorders on Fertility-Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrial Cancer: A Retrospective Study
por: Liu, Sijia, et al.
Publicado: (2022)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases
por: Shan, Ying, et al.
Publicado: (2021)

Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia
por: Zhang, Qing, et al.
Publicado: (2017)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology
por: Ushijima, Kimio, et al.
Publicado: (2023)

Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls
por: Kesterson, Joshua P., et al.
Publicado: (2012)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
por: Moss, Haley A., et al.
Publicado: (2014)

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer
por: Stewart, Katherine Ikard, et al.
Publicado: (2020)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
por: Goncharenko, Vadym M, et al.
Publicado: (2014)

Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study
por: Wang, Yiqin, et al.
Publicado: (2021)

Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia
por: Inoue, Osamu, et al.
Publicado: (2016)

The effect of endometrial thickness on live birth outcomes in women undergoing hormone-replaced frozen embryo transfer
por: Martel, Rachel A., et al.
Publicado: (2021)

Continuous endometrial volumetric analysis for endometrial receptivity assessment on assisted reproductive technology cycles
por: Martins, Renato Silva, et al.
Publicado: (2020)

Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review
por: Wei, Jing, et al.
Publicado: (2017)

Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
por: Zhou, Shuang, et al.
Publicado: (2021)

Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma
por: Xie, Weimin, et al.
Publicado: (2016)

Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2021)

Radiomics-based fertility-sparing treatment in endometrial carcinoma: a review
por: Wang, Yuanjian, et al.
Publicado: (2023)

Effect of endometrial preparation protocols on the risk of ectopic pregnancy for frozen embryo transfer
por: Jwa, Seung Chik, et al.
Publicado: (2021)

Endometrial thickness and early pregnancy complications after frozen-thawed embryo transfers
por: Song, Lin, et al.
Publicado: (2023)

The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome
por: Al-Ghamdi, Ahlam, et al.
Publicado: (2008)

Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Wu, Pengfei, et al.
Publicado: (2022)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
por: Matsuzaki, Toshiya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e1tmqmv60abd4icclfsml6jpa3